{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:10:35Z","timestamp":1790619035637,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1006\/scbi.2001.0412","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T21:19:16Z","timestamp":1032383956000},"page":"455-460","source":"Crossref","is-referenced-by-count":30,"title":["Role of LMP1 in immune control of EBV infection"],"prefix":"10.1006","volume":"11","author":[{"given":"Saparna","family":"Pai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/scbi.2001.0412_RF1","series-title":"Fields Virology","first-page":"2397","article-title":"Epstein\u2013Barr virus","author":"Rickinson","year":"1996"},{"key":"10.1006\/scbi.2001.0412_RF2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.micro.54.1.19","article-title":"Role of cytotoxic T lymphocytes in Epstein\u2013Barr virus-associated diseases","volume":"54","author":"Khanna","year":"2000","journal-title":"Annu Rev Microbiol"},{"key":"10.1006\/scbi.2001.0412_RF3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein\u2013Barr virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1006\/scbi.2001.0412_RF4","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4049\/jimmunol.162.5.3063","article-title":"EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during dcute infectious mononucleosis: Potential use of gp350\/gp85 CTL epitopes for vaccine design","volume":"162","author":"Khanna","year":"1999","journal-title":"J Immunol"},{"key":"10.1006\/scbi.2001.0412_RF5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/268735a0","article-title":"An immunological basis for inhibition of transformation of human lymphocytes by EB virus","volume":"268","author":"Moss","year":"1977","journal-title":"Nature"},{"key":"10.1006\/scbi.2001.0412_RF6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.176.1.169","article-title":"Localization of Epstein\u2013Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development","volume":"176","author":"Khanna","year":"1992","journal-title":"J Exp Med"},{"key":"10.1006\/scbi.2001.0412_RF7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.176.1.157","article-title":"Identification of target antigens for the human cytotoxic T-cell response to Epstein\u2013Barr virus (EBV): implications for the immune control of EBV-positive malignancies","volume":"176","author":"Murray","year":"1992","journal-title":"J Exp Med"},{"key":"10.1006\/scbi.2001.0412_RF8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","article-title":"Inhibition of antigen processing by the internal repeat region of the Epstein\u2013Barr virus nuclear antigen-1","volume":"375","author":"Levitskaya","year":"1995","journal-title":"Nature"},{"key":"10.1006\/scbi.2001.0412_RF9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/MR.59.3.387-405.1995","article-title":"Immune regulation in Epstein\u2013Barr virus-associated diseases","volume":"59","author":"Khanna","year":"1995","journal-title":"Microbiol Rev"},{"key":"10.1006\/scbi.2001.0412_RF10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1440-1711.1998.00717.x","article-title":"Tumour surveillance: missing peptides and MHC molecules","volume":"76","author":"Khanna","year":"1998","journal-title":"Immunol Cell Biol"},{"key":"10.1006\/scbi.2001.0412_RF11","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1128\/JVI.68.11.7374-7385.1994","article-title":"Epstein\u2013Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier","volume":"68","author":"Tierney","year":"1994","journal-title":"J Virol"},{"key":"10.1006\/scbi.2001.0412_RF12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ijc.2910430122","article-title":"A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues","volume":"43","author":"Ling","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1006\/scbi.2001.0412_RF13","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1084\/jem.167.6.1811","article-title":"Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein\u2013Barr virus-positive Burkitt\u2019s lymphoma underlies tumor cell escape from virus-specific T-cell surveillance","volume":"167","author":"Gregory","year":"1988","journal-title":"J Exp Med"},{"key":"10.1006\/scbi.2001.0412_RF14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 signals by Epstein\u2013Barr virus LMP1 in B lymphocyte responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"10.1006\/scbi.2001.0412_RF15","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JVI.64.5.2309-2318.1990","article-title":"Epstein\u2013Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23","volume":"64","author":"Wang","year":"1990","journal-title":"J Virol"},{"key":"10.1006\/scbi.2001.0412_RF16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0008-8749(95)80015-B","article-title":"Upregulation of B7 molecules by the Epstein\u2013Barr virus enhances susceptibility to lysis by a human NK-like cell line","volume":"160","author":"Montel","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1006\/scbi.2001.0412_RF17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/intimm\/6.4.639","article-title":"Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line","volume":"6","author":"Khanna","year":"1994","journal-title":"Int Immunol"},{"key":"10.1006\/scbi.2001.0412_RF18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/eji.1830250536","article-title":"Restoration of endogenous antigen processing in Burkitt\u2019s lymphoma cells by Epstein\u2013Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA class-I antigen expression","volume":"25","author":"Rowe","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1006\/scbi.2001.0412_RF19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0952-7915(93)90077-6","article-title":"Cell biology of antigen presentation","volume":"5","author":"Neefjes","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"10.1006\/scbi.2001.0412_RF20","doi-asserted-by":"crossref","DOI":"10.1006\/scbi.2001.0410","article-title":"LMP1 structure and signal transduction","author":"Eliopoulos","year":"2001","journal-title":"Semin Cancer Biol (current issue)"},{"key":"10.1006\/scbi.2001.0412_RF21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/JVI.75.1.341-350.2001","article-title":"Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein\u2013Barr virus latent membrane protein 1","volume":"75","author":"Zhang","year":"2001","journal-title":"J Virol"},{"key":"10.1006\/scbi.2001.0412_RF22","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.4049\/jimmunol.161.5.2276","article-title":"The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B","volume":"161","author":"Gobin","year":"1998","journal-title":"J Immunol"},{"key":"10.1006\/scbi.2001.0412_RF23","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood.V91.7.2491","article-title":"Expression of the Epstein\u2013Barr virus protein LMP1 mediates tumor regression in vivo","volume":"91","author":"Cherney","year":"1998","journal-title":"Blood"},{"key":"10.1006\/scbi.2001.0412_RF24","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1182\/blood.V92.3.1020","article-title":"Antigen presenting phenotype of Hodgkin Reed\u2013Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on Epstein\u2013Barr virus-specific cytotoxic T-cell recognition","volume":"92","author":"Lee","year":"1998","journal-title":"Blood"},{"key":"10.1006\/scbi.2001.0412_RF25","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/JVI.65.3.1558-1567.1991","article-title":"Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein\u2013Barr virus BNLF-1 5 \u2032 -flanking region","volume":"65","author":"Hu","year":"1991","journal-title":"J Virol"},{"key":"10.1006\/scbi.2001.0412_RF26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/(SICI)1097-0215(19980413)76:2<194::AID-IJC5>3.0.CO;2-S","article-title":"Isolation and analysis of two strongly transforming isoforms of the Epstein\u2013Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin\u2019s lymphoma","volume":"76","author":"Mehl","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1006\/scbi.2001.0412_RF27","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/JVI.70.10.7306-7311.1996","article-title":"Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein\u2013Barr virus variants","volume":"70","author":"Khanna","year":"1996","journal-title":"J Virol"},{"key":"10.1006\/scbi.2001.0412_RF28","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/eji.1830260831","article-title":"Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein\u2013Barr virus latent membrane protein 2","volume":"26","author":"Lee","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1006\/scbi.2001.0412_RF29","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/hum.1998.9.8-1237","article-title":"Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease","volume":"9","author":"Roskrow","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1006\/scbi.2001.0412_RF30","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1073\/pnas.92.13.5845","article-title":"Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design","volume":"92","author":"Thomson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/scbi.2001.0412_RF31","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4049\/jimmunol.160.4.1717","article-title":"Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination","volume":"160","author":"Thomson","year":"1998","journal-title":"J Immunol"},{"key":"10.1006\/scbi.2001.0412_RF32","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1128\/JVI.72.3.2246-2252.1998","article-title":"Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory\/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design","volume":"72","author":"Thomson","year":"1998","journal-title":"J Virol"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X01904122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X01904122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T22:22:04Z","timestamp":1680560524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X01904122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1044579X01904122"],"URL":"https:\/\/doi.org\/10.1006\/scbi.2001.0412","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}